Department of Orthopedic Surgery, Leiden University Medical Center, Postzone J11-R-70, PO Box 9600, 2300 RC Leiden, The Netherlands.
Clin Orthop Relat Res. 2013 Mar;471(3):803-13. doi: 10.1007/s11999-012-2555-5.
Distal radius reconstruction after en bloc tumor resection remains a surgical challenge. Although several surgical techniques, either reconstructing the wrist or achieving a stable arthrodesis, have been described, it is unclear to what degree these restore function.
We describe an updated technique making use of a tibia cortical strut autograft (TCSA) to perform a functional arthrodesis from the remaining radius to the first carpal row. This, in theory, could lead to less donor site morbidity while resulting in a stable but functional and pain-free arthrodesis of the wrist.
Between 1987 and 2010 we reconstructed the wrists of 17 patients using a TCSA arthrodesis (six primary and three revisions), seven with an osteoarticular allograft, three using an ulnar translocation, and one with a fibula autograft. Median age at diagnosis was 24 years (range, 9-58 years) and minimum followup was 2.7 years (median, 13.8 years; range, 2.7-24.5 years). Patients were evaluated using radiographs and clinical examination. We used Musculoskeletal Tumor Society (MSTS), Disabilities of the Arm, Shoulder, and Hand (DASH), and SF-36 questionnaires to assess function and quality of life.
All TCSA reconstructions fused; one patient had a second surgery to expedite union with the carpal row. After osteoarticular allograft, five patients were revised (three to a TCSA) for nonunion, fracture, or joint collapse. ROM and grip strength were comparable in both AO and TCSA, all above 60% of the contralateral side. Median MSTS and DASH scores were 73% and 6, respectively, and did not differ between the groups. The SF-36 scores showed less pain after TCSA; otherwise, all patients presented with comparable function.
TCSA wrist arthrodesis resulted in a functional and painless wrist reconstruction with a relatively low complication and donor site morbidity rate and comparable functional results as other techniques.
Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
整块肿瘤切除后桡骨远端的重建仍然是一个手术挑战。虽然已经描述了几种手术技术,无论是重建腕关节还是实现稳定的关节融合,都不清楚这些技术在多大程度上恢复了功能。
我们描述了一种更新的技术,利用胫骨皮质骨支撑移植物(TCSA)从剩余的桡骨到第一腕掌骨进行功能性关节融合。从理论上讲,这可以减少供体部位的发病率,同时导致腕关节稳定但功能正常且无痛的融合。
在 1987 年至 2010 年间,我们使用 TCSA 融合术重建了 17 例患者的手腕(6 例原发性和 3 例翻修),其中 7 例使用了骨软骨同种异体移植物,3 例使用了尺骨移位,1 例使用了腓骨自体移植物。诊断时的中位年龄为 24 岁(范围为 9-58 岁),最短随访时间为 2.7 年(中位数为 13.8 年;范围为 2.7-24.5 年)。患者通过影像学检查和临床检查进行评估。我们使用肌肉骨骼肿瘤协会(MSTS)、手臂、肩部和手残疾(DASH)和 SF-36 问卷来评估功能和生活质量。
所有 TCSA 重建均融合;一名患者因与腕掌骨融合而进行了第二次手术。在使用骨软骨同种异体移植物后,有 5 例患者因非融合、骨折或关节塌陷而进行了翻修(其中 3 例翻修为 TCSA)。桡侧和 TCSA 的 ROM 和握力均相似,均高于对侧的 60%。中位 MSTS 和 DASH 评分分别为 73%和 6,两组之间无差异。SF-36 评分显示 TCSA 后疼痛减轻;否则,所有患者的功能均相似。
TCSA 腕关节融合术可重建功能正常且无痛的腕关节,并发症和供体部位发病率相对较低,功能结果与其他技术相当。
III 级,治疗研究。有关完整的证据水平描述,请参见作者指南。